Comparative metabolism of cannabidiol in dog, rat and man - PubMed (original) (raw)
Comparative Study
Comparative metabolism of cannabidiol in dog, rat and man
D J Harvey et al. Pharmacol Biochem Behav. 1991 Nov.
Abstract
Urinary metabolites of cannabidiol (CBD) were extracted from human, dog and rat urine, concentrated by chromatography on Sephadex LH-20, and identified by GC/MS. Over 50 metabolites were identified with considerable species variation. CBD was excreted in substantial concentration from human urine, both in the free state and as its glucuronide. In dog, unusual glucoside conjugates of three metabolites (4''- and 5''-hydroxy and 6-oxo-CBD), not excreted in the unconjugated state, were found as the major metabolites at early times after drug administration. Other metabolites in all three species were mainly acids. Side-chain hydroxylated derivatives of CBD-7-oic acid were particularly abundant in human urine but much less so in dog. In the latter species the major oxidized metabolites were the products of beta-oxidation with further hydroxylation at C-6. A related, but undefined pathway, resulted in loss of three carbon atoms from the side-chain of CBD in man with the production of 2''-hydroxy-tris,nor-CBD-7-oic acid. Previous experiments indicate that 3'-hydroxy-metabolites are the precursors of compounds having this side-chain. Metabolism by the epoxide-diol pathway, resulting in dihydro-diol formation from the delta-8-double bond, gave metabolites in both dog and human urine. It was concluded that CBD could be used as a probe of the mechanism of several types of biotransformation, particularly those related to carboxylic acid metabolism, as intermediates of the type not usually seen with endogenous compounds were excreted in substantial concentration.
Similar articles
- Urinary metabolites of cannabidiol in dog, rat and man and their identification by gas chromatography-mass spectrometry.
Harvey DJ, Samara E, Mechoulam R. Harvey DJ, et al. J Chromatogr. 1991 Jan 2;562(1-2):299-322. doi: 10.1016/0378-4347(91)80587-3. J Chromatogr. 1991. PMID: 2026700 - Identification of urinary metabolites of cannabidiol in the dog.
Samara E, Bialer M, Harvey DJ. Samara E, et al. Drug Metab Dispos. 1990 Sep-Oct;18(5):571-9. Drug Metab Dispos. 1990. PMID: 1981704 - Metabolism of cannabidiol by the rat.
Samara E, Bialer M, Harvey DJ. Samara E, et al. Eur J Drug Metab Pharmacokinet. 1991 Oct-Dec;16(4):305-13. doi: 10.1007/BF03189976. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1823875 - Metabolites of cannabidiol identified in human urine.
Harvey DJ, Mechoulam R. Harvey DJ, et al. Xenobiotica. 1990 Mar;20(3):303-20. doi: 10.3109/00498259009046849. Xenobiotica. 1990. PMID: 2336840 - Identification of metabolites of the 1",1"-dimethylheptyl analogue of cannabidiol in rat and dog in vivo.
Samara E, Bialer M, Bar-On H, Harvey DJ. Samara E, et al. Xenobiotica. 1990 May;20(5):447-55. doi: 10.3109/00498259009046860. Xenobiotica. 1990. PMID: 2349804
Cited by
- Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine.
Bergamaschi MM, Barnes A, Queiroz RH, Hurd YL, Huestis MA. Bergamaschi MM, et al. Anal Bioanal Chem. 2013 May;405(14):4679-89. doi: 10.1007/s00216-013-6837-x. Epub 2013 Mar 15. Anal Bioanal Chem. 2013. PMID: 23494274 Free PMC article. - Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
Mukhopadhyay P, Rajesh M, Horváth B, Bátkai S, Park O, Tanchian G, Gao RY, Patel V, Wink DA, Liaudet L, Haskó G, Mechoulam R, Pacher P. Mukhopadhyay P, et al. Free Radic Biol Med. 2011 May 15;50(10):1368-81. doi: 10.1016/j.freeradbiomed.2011.02.021. Epub 2011 Mar 11. Free Radic Biol Med. 2011. PMID: 21362471 Free PMC article. - Efficacy and tolerability of full spectrum hemp oil in dogs living with pain in common household settings.
Panda C, Rathinasabapathy T, Metzger B, Dodson S, Hanson D, Griffiths J, Komarnytsky S. Panda C, et al. Front Vet Sci. 2024 Jul 12;11:1384168. doi: 10.3389/fvets.2024.1384168. eCollection 2024. Front Vet Sci. 2024. PMID: 39071787 Free PMC article. - Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract.
Wakshlag JJ, Schwark WS, Deabold KA, Talsma BN, Cital S, Lyubimov A, Iqbal A, Zakharov A. Wakshlag JJ, et al. Front Vet Sci. 2020 Sep 4;7:505. doi: 10.3389/fvets.2020.00505. eCollection 2020. Front Vet Sci. 2020. PMID: 33102539 Free PMC article. - Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats.
Deabold KA, Schwark WS, Wolf L, Wakshlag JJ. Deabold KA, et al. Animals (Basel). 2019 Oct 19;9(10):832. doi: 10.3390/ani9100832. Animals (Basel). 2019. PMID: 31635105 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous